We’ll Just Monitor It: What Watchful Waiting Really Means in Retina Care
What Your Doctor Means by We Will Just Monitor It
Monitoring is safe as long as you know when to stop waiting. Call your eye doctor the same day, or go to the emergency room if you cannot reach them, for any of these:
- A sudden loss of vision, in one eye or both.
- A curtain or shadow moving across your sight.
- A sudden shower of new floaters.
- New flashing lights, especially with floaters.
- Straight lines that have started to look bent or wavy.
- A new dark or blank patch in the middle of your vision.
None of these mean the worst has happened. Many turn out to be minor. But they are the changes that monitoring is built to catch, and catching them early is the whole point of the plan you are on.
It is an active plan with a schedule, not an absence of care. Your doctor has found something, judged that treating it now would not help you more than watching it, and set a date to look again. Between those dates you are the monitor. The plan has three parts: the interval, the tests done at each visit, and the list of changes that bring you back sooner.
For some findings, treatment has never been shown to beat observation. A Cochrane review searching the literature to January 2012 looked for trials of treating retinal breaks and lattice degeneration that were causing no symptoms, and found no randomized controlled trials that met its criteria, so no conclusion could be drawn about whether that treatment helps1. Watching is not your doctor withholding something useful. Sometimes it is the honest answer to a genuinely open question.
It does not mean your finding is imaginary, or that nothing will ever be done. It does not mean you should skip the follow-up because you feel fine, since some changes are silent at first. Periodic dilated examinations exist precisely to catch people whose macular degeneration progresses without causing symptoms2. Feeling well is not evidence that nothing has changed. That is exactly why the interval exists.
The Retina Findings That Are Usually Watched
This is the most common reason for a monitoring plan in retina care. Age-related macular degeneration is staged as early, with small or intermediate drusen, intermediate, with extensive small or intermediate drusen or any large drusen, and advanced, meaning geographic atrophy or a new vessel membrane2. Treatment options for the dry form are limited, while the wet form is treated with anti-VEGF injections2. So monitoring is aimed at catching the switch to the wet form early.
Many people are told they have a thin patch in the peripheral retina and then hear nothing more about it. Lattice degeneration is a thinning of the peripheral retina present in about 6 to 8 of every 100 people, and about 33 of every 100 nearsighted eyes3. Only about 0.7 of every 100 people with it go on to a clinical retinal detachment, and prophylactic treatment is not generally advocated3.
Some fluid at the macula is watched because it often drains without help. A review from the American Academy of Ophthalmology reports that in acute central serous chorioretinopathy the fluid clears without treatment within 6 months in most people, with reported figures across studies ranging from about 84 to 100 of every 100 cases and clearing most often within 3 to 4 months, and that review suggests deferring treatment over those first 3 to 4 months for that reason4. Earlier treatment is considered for people who need rapid recovery for work, for those with only one seeing eye, and for long running or repeated episodes4.
Getting Ready for a Monitoring Visit
Bring your glasses, a list of your medicines, and sunglasses for afterwards. Arrange a ride home for your first dilated visit until you know how you react, because near vision stays blurry for a few hours. Bring a note of anything you have noticed since last time, even if it sounds trivial. The small things you have stopped mentioning are often the useful ones.
Drops widen the pupil so your doctor can see the far edges of the retina, not just the center. Without dilation, a good deal of the retina simply cannot be examined. The drops sting briefly and take about 20 minutes to work. Expect light sensitivity and blurred near vision for a few hours afterwards, and expect the appointment to run longer than you think.
Say if you have noticed any change in your vision, however small, and when it started. Mention any new medicines, particularly steroids in any form, including creams, inhalers, and injections. Steroid exposure is the strongest known association with central serous chorioretinopathy4. Mention if driving or work is becoming harder. That changes the conversation about when watching should stop.
What Actually Happens at a Monitoring Visit
The visit starts with the letter chart, one eye at a time, and it matters more than it looks. Your reading on the chart is compared against the last one, so a small drop is a signal even if you had not noticed it. Eye pressure is usually checked too. Neither test hurts, and both take a couple of minutes.
A scan called optical coherence tomography takes a cross section through the retina, layer by layer, without touching your eye. Optical coherence tomography has become indispensable in the assessment of macular degeneration2. It shows fluid and thickening long before you would notice a change yourself. This is usually the test that decides whether your plan stays as it is or changes.
Once the drops have worked, your doctor examines the retina with a bright light and a lens. This is how peripheral findings are followed, since scans of the macula do not show the far edges well. It is uncomfortable rather than painful. Photographs are often taken as well, so this visit can be compared against the next one rather than relying on memory.
The Watching You Do at Home
An Amsler grid is a square of fine lines with a dot in the middle. People with macular degeneration, particularly the dry form, are advised to use one once a day, every day5. The steps are: wear whatever glasses you normally read in, hold the grid 12 to 15 inches from your face in good light, cover one eye, look directly at the center dot and keep your eye on it, and notice in your side vision whether any lines or areas look blurry, wavy, dark, or blank, then repeat with the other eye5. Testing one eye at a time is what makes it work.
A home monitoring device can find the switch to wet macular degeneration earlier than routine care alone. In a randomized trial of 1,520 people at high risk, among the 82 who went on to develop new vessels, those using a home hyperacuity device had lost a median of 4 letters of vision by the time it was picked up, against 9 letters under standard care, and 87 of every 100 device users still had vision of 20/40 or better at detection against 62 of every 100 under standard care. The trial was stopped early once its efficacy threshold was met6. Ask whether you qualify.
Check each eye separately, at the same time and in the same place each day, and write down what you find. Your better eye hides changes in the weaker one, which is why people are often shocked at how much vision one eye has quietly lost. A phone reminder and a note on the calendar work better than intending to remember. Bring those notes to your visit.
What Stable Really Means
Stable means today's scan and examination look like last time's. It is a statement about the past interval, not a forecast for the next one. That is why the interval itself is part of the plan, and why it may shorten if your risk changes. Ask what your doctor is comparing against, and what they would need to see to call it a change.
A macular scan is detailed at the center and limited at the edges, so it can be reassuring about one part of your retina while saying nothing about another. That is why the dilated examination is done as well. A normal result today also cannot tell you about tomorrow. It is a snapshot, and the reason you are given warning signs is that snapshots have gaps between them.
Usually one of three things: a change you report, a drop on the vision chart, or something new on the scan or examination. The changes of wet macular degeneration may be associated with a drop in vision that comes on over hours to days, or with visual distortion, meaning straight lines that look bent or objects that look smaller than they are2. Report anything like that to your team promptly rather than saving it for your next date, and ask your own doctor which specific finding would change your plan.
The Risks of Watching, Honestly
The real risk of watchful waiting is a change that goes unnoticed until it has already cost vision. That is the cost the whole plan is designed against, and it is why the reporting rules matter more than the appointment dates. In the home monitoring trial, earlier detection meant less vision lost by the time treatment began6. The plan works when the interval and your own reporting work together.
Every treatment carries its own risks, and treating a finding that would never have caused trouble means taking those risks for no gain. The Cochrane review of treating symptomless retinal breaks and lattice degeneration noted that some treatment recommendations based on expert consensus are contradicted by the best available evidence, and that most retinal detachments arise in retina that had looked normal rather than at visible lesions1. Watching is a decision, not a delay.
There is no single interval, and yours depends on the finding, your other eye, and your risk, so ask what yours is and what sets it. What matters is that you know your date and that it is actually booked before you leave. If there is no appointment on the calendar, the monitoring plan is not running, whatever the notes say.
When and How to Call Between Visits
Anything sudden is urgent: a sudden change in vision, a sudden crop of floaters, new flashes, or a curtain in your sight. Some people with lattice degeneration first come in with the symptoms of a complication such as a retinal tear or detachment, and those symptoms may include flashes of light, floaters, loss of side vision, or loss of vision3. Those are the ones to report, not to wait out. Slow changes over weeks, like reading getting harder, deserve a call in office hours rather than a wait until your next date.
Lead with the three facts the office needs: which eye, what changed, and when it started. Say whether it came on suddenly. Mention that you are on a monitoring plan and name the finding if you know it. That framing gets you triaged properly. Vague calls tend to get routine appointments, and this is not the moment to understate things.
For sudden vision loss, a curtain across your sight, or a sudden shower of floaters with flashes, do not spend the day on hold. Go to an emergency department or an urgent eye service. For anything less dramatic, leave a clear message and call again rather than assuming it was passed on. Ask for the direct number for urgent problems and keep it with your appointment card.
Questions People Ask About Being Monitored
Not exactly. It means treating it today is not expected to leave you better off than watching it carefully. Some watched findings are genuinely minor. Only about 0.7 of every 100 people with lattice degeneration go on to a clinical retinal detachment3. Others are serious conditions in an early phase, where the plan is to act at the right moment rather than the earliest one. Ask which of the two yours is.
Partly, and this is the most common misunderstanding. Reporting changes is essential, but it does not replace the scheduled visit, because some changes cause no symptoms at all until later. Periodic dilated examinations exist to identify people who progress without having symptoms2. Do both: keep the appointment, and call in between if anything changes. One is not a substitute for the other.
It is useful and it is not sufficient. People with macular degeneration are advised to use the grid once a day, and to contact their ophthalmologist right away if any area of it looks darker, wavy, blank, or blurry5, but a home hyperacuity device did better than standard self-monitoring in a randomized trial, with less vision lost by the time new vessels were found6. Use the grid properly, one eye at a time, and ask your doctor whether a home device or a shorter interval suits your risk.
Say so, and ask for the specific trade-off in your case. For some findings there is a real choice, and your preferences count. For others the evidence for early treatment is genuinely absent. A Cochrane review found no randomized trials of treating symptomless retinal breaks or lattice degeneration1. Asking what treatment would offer you, and what it would cost you, usually moves the conversation further than asking for it outright.
Most people on a monitoring plan do not, but nobody can promise your own result. That is why the plan pairs a fixed interval with a list of changes to report the same day. When new vessels were detected earlier in a randomized trial, people had lost less vision by the time treatment started6. The earlier a change is caught, the more room your team has to act.
More Questions About Living With a Monitoring Plan
Not automatically, and this is a question for your own clinician and your licensing authority rather than for you alone. Being monitored is not the same as being unsafe to drive. What matters is your actual vision, your field of vision, and whether either has changed. Ask for a straight answer at your next visit, and ask what change would mean stopping. Do not simply decide alone in either direction.
They do not replace it. Treatment options for dry macular degeneration are limited and include antioxidant and mineral supplementation2. Whether a supplement suits you depends on your stage and your other health conditions, so ask your own doctor rather than starting one from a shelf. Whatever you decide about supplements, the monitoring interval and the warning signs stay the same.
Intervals reflect risk, not just today's picture. A change in your other eye, a new finding on a scan, a new medicine, or simply moving from one stage to another can all shorten the gap. Steroid exposure, for example, is the strongest known association with central serous chorioretinopathy4. Ask what specifically prompted the change, because the answer usually tells you what your team is watching for.
No. Many findings are watched for years and never need treating. As one American Academy of Ophthalmology review describes it, most acute central serous chorioretinopathy settles without treatment within 6 months4, and prophylactic treatment for lattice degeneration alone is not generally advocated3. Others do move to treatment, and monitoring is what makes that move happen at a useful moment. Neither outcome is decided in advance by the fact that you are being watched.
- What exactly did you find, and which eye is it in?
- What would have to change for you to treat this instead of watching it?
- How often will I be seen, and is my next appointment booked?
- Which specific symptoms should make me call the same day?
- Should I be using an Amsler grid or a home monitoring device?
- What is my vision measurement today, so we have a baseline to compare against?
- Cochrane Database of Systematic Reviews, Cochrane Eyes and Vision Group (PubMed Central PMC4730545) (2012). Interventions for asymptomatic retinal breaks and lattice degeneration for preventing retinal detachment.
- EyeWiki, American Academy of Ophthalmology (2026). Age-Related Macular Degeneration (EyeWiki).
- EyeWiki, American Academy of Ophthalmology (2026). Lattice Degeneration (EyeWiki).
- EyeWiki, American Academy of Ophthalmology (2024). Central Serous Chorioretinopathy (EyeWiki).
- American Academy of Ophthalmology, EyeSmart patient education (2025). All About the Amsler Grid and Daily Vision Checks for AMD.
- Ophthalmology; unmasked randomized controlled trial at 44 AREDS2 clinical centers (PubMed Central PMC3918479) (2014). Randomized Trial of a Home Monitoring System for Early Detection of Choroidal Neovascularization: HOme Monitoring of the Eye (HOME) Study.